[Glycoprotein P-170, associated with multidrug resistance, in patients with acute leukemia in complete remission].
Divisione di Ematologia, Ospedale Generale Regionale Casa Sollievo della Sofferenza, S. Giovanni Rotondo.
P
P
Musto
M
M
Carotenuto
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000276:immunology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000276:immunology; D004351:Drug Resistance; D006801:Humans; D007124:Immunoenzyme Techniques; D007938:Leukemia / Q000145:classification / Q000188:drug therapy* / Q000201:enzymology; D008562:Membrane Glycoproteins / Q000032:analysis* / Q000276:immunology; D009363:Neoplasm Proteins / Q000032:analysis* / Q000276:immunology; D010641:Phenotype; D012074:Remission Induction
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; D008562:Membrane Glycoproteins; D009363:Neoplasm Proteins
Studio della glicoproteina P-170, associata alla "multidrug resistance", in pazienti affetti da leucemia acuta in fase di remissione completa.